Roche Gets Long-Awaited Green Light For COVID-19 Cocktail In EU

Regulator’s Chief Intervenes To Speed Availability

 
• By Andrew McConaghie
Roche
Roche will add the antibody cocktail to its diagnostics and acute therapy Actemra being used to tackle COVID-19.

More from Business

More from Scrip